Trial intelligence / Profile preview

Comparison of modified iliac fascia block and PENG block plus local infiltration in total hip arthroplasty

ChiCTR2200065321Phase 4Completed

Sponsor
Hefei First People's Hospital
Start
Nov 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Hefei First People's Hospital. Primary endpoints: Postoperative muscle strength and Postoperative pain. Started Nov 2022; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2200065321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200065321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call